Gene Therapy
Studies from National Taiwan University, Institute of Pathology further understanding of gene therapy
Published in Gene Therapy Weekly, February 8th, 2007
A new study, "L2dtl is essential for cell survival and nuclear division in early mouse embryonic development," is now available. "l(2)dtl (lethal (2) denticleless), is an embryonic lethal homozygous mutation initially identified in Drosophila melanogaster that produces embryos that lack ventral denticle belts. In addition to nucleotide sequence, bioinformatic analysis has revealed a conservation of critical functional motifs among the human L2DTL, mouse L2dtl, and Drosophila l(2)dtl proteins," scientists writing in the Journal of Biological Chemistry report.
"The function of the L2DTL protein in the development of mammalian embryos was studied using...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-02-08)
More Articles from Gene Therapy Weekly
- Lung Cancer
Dual gene therapy suppresses lung cancer in preclinical test - Bird Flu Gene Therapy
Studies from Chulalongkorn University, Faculty of Veterinary Science further understanding of bird flu gene therapy - Brain Cancer Therapy
Research reports on brain cancer therapy from University of California, Brain Tumor Research Center provide new insights - Cancer Gene Therapy
Data on cancer gene therapy reported by researchers at University of Arizona, Arizona Cancer Center - Cancer Gene Therapy
New cancer gene therapy study results reported from Kyoto University - Cancer Gene Therapy
Recent findings from University of Texas, M. D. Anderson Cancer Center highlight research in cancer gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
